March 23 (Reuters) -
* GILEAD NEARS UP TO $2BN DEAL FOR AUTOIMMUNE BIOTECH OURO
MEDICINES - FT
* GILEAD WILL PAY PRIVATELY HELD OURO'S INVESTORS ROUGHLY
$1.5BN UPFRONT IN CASH AND AT LEAST EXTRA $500MN IF CERTAIN
CLINICAL TRIAL MILESTONES ARE HIT - FT
* TALKS BETWEEN GILEAD AND OURO MEDICINES ARE AT AN ADVANCED
STAGE AND A DEAL COULD BE ANNOUNCED IN THE COMING DAYS - FT
Source text: https://tinyurl.com/3jye8yjx
Further company coverage: